The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age10-18
SponsorUniversity of California, San Francisco

About this trial

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery.

The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of Adolescent Idiopathic Scoliosis (AIS) or neuromuscular scoliosis

Undergoing Posterior Spinal Fusion (PSF) Surgery

Disqualifiers

Patients with forms of scoliosis other than AIS or NM Scoliosis.

Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery

Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ropivacaine Hydrocloride

    Drug

    This drug is approved as a local anesthetic.

Treatment groups

42 Participants
are divided into 2 treatment groups
Group A: ESPB with Ropivacaine + standard postoperative pain protocolExperimental treatment 1 intervention
Group B: No ESPB + standard postoperative pain protocolNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Compare Oral Morphine Equivalents and Benzodiazepine Doses used in the first 72 hours after surgery among patients who have a ESPB with standard postoperative pain protocols versus those with standard protocols alone.

Institutional pain management protocol: patients have a hydromorphone patient-controlled analgesia pump until post-operative day 1 and as needed (PO) methadone two times a day, as well as PO oxycodone every 4 hours as needed for moderate pain and IV hydromorphone every 2 hours as needed for severe pain. PO diazepam is available every 6 hours for muscle spasms. The oral morphine equivalents and benzodiazepine doses used in the first 72 hours after surgery will be the primary method of assessing postoperative pain and muscle spasms respectively.

Time frame
Change from Baseline to 72 hours after surgery.
2

Evaluate if combining ESPBs with standard postoperative pain protocols reduce postoperative pain scores in the first 24 hours postoperatively as compared to standard protocols alone.

Pain will be measured on a numerical scale from zero to ten, with zero being no pain at all and ten being the worst pain you have ever felt. Scores will be gathered at multiple time points the day of surgery, and post-op day 1, 2 and 3. We will take the average pain score. These numerical pain scores will be the secondary method of assessing postoperative pain.

Time frame
From Baseline to 24 hours after surgery.
3

Assess time to clearance from physical therapy among patients who have a ESPB with standard postoperative pain protocols versus those with standard protocols alone.

Time to clearance from physical therapy (PT) is a measure that demonstrates the amount of time required to obtain a functional level of mobilization after surgery. This mobilization is often pain limited. For neuromuscular patients with mobility limitations, aim 3 will be measured based on when patients are cleared by PT for safe discharge home. We will measure time to clearance in both groups.

Time frame
From postoperative day 1 to physical therapy clearance.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.